---
title: NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in
  MLL-r B-ALL by regulating NR3C1 expression
date: '2024-08-02'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39093982/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240803181345&v=2.18.0.post9+e462414
source: Blood
description: B-cell acute lymphoblastic leukemia (B-ALL) is the most common pediatric
  cancer, with long-term overall survival rates of ~85%. However, B-ALL harboring
  rearrangements of the MLL gene (also known as KMT2A), referred to as MLLr B-ALL,
  is common in infants and is associated with poor 5-year survival (<30%), frequent
  relapses, and refractoriness to glucocorticoids (GCs). GCs are an essential part
  of the treatment backbone for B-ALL and GC resistance is a major clinical predictor
  of poor ...
disable_comments: true
---
B-cell acute lymphoblastic leukemia (B-ALL) is the most common pediatric cancer, with long-term overall survival rates of ~85%. However, B-ALL harboring rearrangements of the MLL gene (also known as KMT2A), referred to as MLLr B-ALL, is common in infants and is associated with poor 5-year survival (<30%), frequent relapses, and refractoriness to glucocorticoids (GCs). GCs are an essential part of the treatment backbone for B-ALL and GC resistance is a major clinical predictor of poor ...